(1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-,
(1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-, monohydrochloride,
4''-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide,
conivaptan,
conivaptan hydrochloride,
Vaprisol,
YM 087,
YM087,
Conivaptan hydrochloride,
168626-94-6,
Conivaptan HCl,
Vaprisol,
YM 087,
Conivaptan (hydrochloride),
Conivaptan hydrochloride [USAN],
UNII-75L57R6X36,
Conivaptan HCl (Vaprisol),
CI-1025,
CHEBI:31430,
YM-087,
75L57R6X36,
N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide hydrochloride,
AK104672,
(1,1'-Biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-, monohydrochloride,
4'-((4,5-Dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide monohydrochloride,
C32H27ClN4O2,
[1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, hydrochloride (1:1),
4'-[(2-Methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)-carbonyl]-2-phenylbenzanilide monohydrochloride,
8626-94-6,
N-(4-(2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxamide hydrochloride,
SMR004701209,
Vaprisol (TN),
conivaptan-hcl-vaprisol,
AC1Q3DXX,
MLS006010030,
MLS006010233,
SCHEMBL387232,
AC1L50I9,
CHEMBL1201108,
DTXSID70168585,
EBD4965,
BTYHAFSDANBVMJ-UHFFFAOYSA-N,
Vaprisol, Conivaptan hydrochloride,
BCP28426,
EX-A1128,
KS-00000QO3,
AN-986,
Conivaptan hydrochloride (JAN/USAN),
HY-18347A,
MFCD00945712,
s2116,
AKOS015994583,
AKOS025401635,
API0002107,
CS-2015,
FE-0225,
MP-1696,
AC-23918,
BC677679,
LS-44227,
n-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1h)-yl)carbonyl]phenyl}biphenyl-2-carboxamidhydrochlorid,
AB2000519,
AX8238880,
AM20090724,
FT-0657174,
ST24024699,
SW219215-1,
Y0319,
D01236,
626C946,
A818981,
J-010472,
4'-[(2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)carbonyl]-2-phenylbenzanilide hydrochloride,
N-[4-(2-methyl-4,5-dihydro-1H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide;hydrochloride,
N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenyl-benzamide hydrochloride,
N-[4-[(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepin-6-yl)-oxomethyl]phenyl]-2-phenylbenzamide hydrochloride,
N-[4-[(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepin-6-yl)carbonyl]phenyl]-2-phenyl-benzamide hydrochloride,
N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1'-Biphenyl]-2-carboxamide Hydrochloride,
N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide hydrochloride,
Conivaptan,
C32H20N4O2.ClH,
YM087,
C32-H20-N4-O2.Cl-H,
AR-1K4737,
CID216322,
ACN-057387,
CS-O-10463,
A8402,
C106389,
2725-81-7,
(1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-,
4''-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide,